Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleeping sickness: PEX and drugs.

Wolfgang Schliebs1

  • 1Institute für Physiologische Chemie, Abt. Systembiochemie, Ruhr-Universität Bochum, D-44780, Germany. wolfgang.schliebs@rub.de

Biochimica Et Biophysica Acta
|February 14, 2006
PubMed
Summary

Developing new treatments for parasitic diseases like sleeping sickness is crucial. Understanding glycosome biogenesis in trypanosomes offers potential new drug targets for these fatal illnesses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-confidence glycosomal membrane protein inventory unveils trypanosomal peroxin PEX15.

Cell reports·2025
Same author

Modulation of peroxisomal import by the PEX13 SH3 domain and a proximal FxxxF binding motif.

Nature communications·2024
Same author

PEX1 is essential for glycosome biogenesis and trypanosomatid parasite survival.

Frontiers in cellular and infection microbiology·2024
Same author

Quantitative analysis of peroxisome tracks using a Hidden Markov Model.

Scientific reports·2023
Same author

Molecular basis of the glycosomal targeting of PEX11 and its mislocalization to mitochondrion in trypanosomes.

Frontiers in cell and developmental biology·2023
Same author

Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template.

European journal of medicinal chemistry·2023

Area of Science:

  • Biomedical Research
  • Parasitology
  • Molecular Biology

Background:

  • Human sleeping sickness is a fatal parasitic disease requiring novel therapeutic strategies.
  • Trypanosomes, the causative agents, possess unique organelles called glycosomes.
  • Glycosomes are peroxisome-related organelles vital for parasite survival.

Purpose of the Study:

  • To explore the potential of glycosome biogenesis as a novel drug development target.
  • To identify new therapeutic avenues for treating human sleeping sickness.

Main Methods:

  • Investigating the molecular mechanisms of glycosome biogenesis.
  • Analyzing the role of glycosomes in trypanosome survival and pathogenesis.

Main Results:

  • Elucidating key pathways in glycosome formation and maintenance.
  • Identifying specific proteins or processes involved in glycosome biogenesis.

Conclusions:

  • The biogenesis of glycosomes presents a promising target for anti-parasitic drug development.
  • Targeting glycosome pathways could lead to effective treatments for sleeping sickness.

Related Experiment Videos